Article Text

Download PDFPDF
Review: angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation

Statistics from


  • For correspondence: Dr J Healey, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada. healeyj{at}

  • Sources of funding: Heart and Stroke Foundation of Canada and Astra-Zeneca Canada Limited.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.